Cargando…

β-blocker and 1-year outcomes among patients hospitalized for heart failure with mid-range ejection fraction

AIMS: The beneficial effect of β-blocker on heart failure with reduced ejection fraction is well established. However, its effect on the 1-year outcome of heart failure with mid-range ejection fraction (HFmrEF) remains unclear. METHODS AND RESULTS: We analysed the data of the patients with left vent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bin, Zhang, Lihua, Hu, Shuang, Bai, Xueke, Zhang, Haibo, Li, Xi, Li, Jing, Zheng, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847069/ https://www.ncbi.nlm.nih.gov/pubmed/33774652 http://dx.doi.org/10.1093/ehjcvp/pvab029

Ejemplares similares

Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction
por: Wang, Bin, et al.
Publicado: (2021)

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Heart Failure with Mid-Range Ejection Fraction - State of the Art
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2019)

Heart failure with mid-range or mildly reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2021)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence
por: Koufou, Eleni-Evangelia, et al.
Publicado: (2021)

Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction
por: Maeder, Micha T., et al.
Publicado: (2021)

The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
por: Xin, Yanguo, et al.
Publicado: (2019)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
por: Margonato, Davide, et al.
Publicado: (2020)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
por: Zhu, Kaiyuan, et al.
Publicado: (2021)

Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials
por: Xiang, Yajie, et al.
Publicado: (2019)

Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?
por: Zhou, Qing, et al.
Publicado: (2021)

Heart failure with mid‐range ejection fraction: characterization of patients from the PINNACLE Registry®
por: Ibrahim, Nasrien E., et al.
Publicado: (2019)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
por: Borrelli, Chiara, et al.
Publicado: (2019)

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
por: Enzan, Nobuyuki, et al.
Publicado: (2020)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
por: Santas, Enrique, et al.
Publicado: (2020)

Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence
por: Ma, Teng, et al.
Publicado: (2021)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction: The Misleading Definition of the New Guidelines
por: Fedele, Francesco, et al.
Publicado: (2017)

Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure
por: Oliveira, Márcia Maria Carneiro, et al.
Publicado: (2018)

The prognosis of mid‐range ejection fraction heart failure: a systematic review and meta‐analysis
por: Altaie, Saif, et al.
Publicado: (2018)

Particularities of Older Patients with Obstructive Sleep Apnea and Heart Failure with Mid-Range Ejection Fraction
por: Ardelean, Carmen Loredana, et al.
Publicado: (2019)

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
por: Son, Mi Kyoung, et al.
Publicado: (2020)

Impact of diastolic dysfunction on outcome in heart failure patients with mid‐range or reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2021)

Prognostic value of reverse remodelling criteria in heart failure with reduced or mid‐range ejection fraction
por: Aimo, Alberto, et al.
Publicado: (2021)

Atrial fibrillation ablation in heart failure with mid-range ejection fraction: Is it time to open the champagne?
por: Nagarakanti, Rangadham, et al.
Publicado: (2023)

Prognostic value of heart failure echocardiography index in HF patients with preserved, mid-ranged and reduced ejection fraction
por: Chen, Jian-Shu, et al.
Publicado: (2020)

Changes in the Left Ventricular Ejection Fraction and Outcomes in Hospitalized Heart Failure Patients with Mid-range Ejection Fraction: A Prospective Observational Study
por: Tsukamoto, Kei, et al.
Publicado: (2020)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Publicado: (2013)

The Value of IGF-1 and IGFBP-1 in Patients With Heart Failure With Reduced, Mid-range, and Preserved Ejection Fraction
por: Guo, Shaohua, et al.
Publicado: (2022)

Clinical characteristics of hospitalized heart failure patients with preserved, mid‐range, and reduced ejection fractions in Japan
por: Shiga, Tsuyoshi, et al.
Publicado: (2019)

Predictors of cardiac function in acute heart failure patients with mid‐range ejection fraction: AURORA study
por: Yanagawa, Kyosuke, et al.
Publicado: (2019)

Gender disparities in heart failure with mid-range and preserved ejection fraction: Results from APOLLON study
por: Özlek, Bülent, et al.
Publicado: (2019)

Trends in cause‐specific readmissions in heart failure with preserved vs. reduced and mid‐range ejection fraction
por: Cui, Xiaotong, et al.
Publicado: (2020)

Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction
por: Zhu, Ning, et al.
Publicado: (2019)

Assessment of right ventricular systolic function in heart failure with preserved, reduced and mid-range ejection fraction
por: Mostafa, Shaimaa
Publicado: (2019)

Left atrial function and maximal exercise capacity in heart failure with preserved and mid‐range ejection fraction
por: Maffeis, Caterina, et al.
Publicado: (2020)

Suppression of acute heart failure rehospitalization by biventricular pacing in wide QRS and mid‐range ejection fraction
por: Akamine, Koshiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1tiavfass7ktl89g0a0gpte0h